FTRE Fortrea Holdings Inc: Business Value to Revenue

Public company logo of fortrea.com (FTRE)

The price-to-sales multiple for Fortrea Holdings Inc. (FTRE) exhibits current volatility, with the indicator reaching 1065.84. This trend is driven by the implementation of AI in decentralized trials and IT restructuring. The business foundation relies on global CRO expertise and massive patient databases; however, geopolitical tensions and sanctions seriously complicate the cross-border exchange of biosamples and the execution of large-scale studies.

FTRE (Fortrea Clinical) Enterprise Value-to-Revenue Ratio history from 11/23/2025 to 11/20/2026

Fortrea Holdings Inc - analytical breakdowns and key metrics (FTRE)

- price and consensus price forecast:
- money and cash flow information:
Fundamental valuation:Fortrea Holdings Inc. FTRE
Core merchandise of Fortrea

Institutional investors utilize this metric to determine the fair value of Fortrea Holdings Inc. (FTRE) excluding debt load. The EV/Sales ratio compares the total enterprise value of the business with the volume of generated revenue. The EV/Sales trend allows for the identification of whether the asset is overbought or if its operational capacities are undervalued. For Fortrea Holdings Inc. (FTRE), such a metric confirms a capitalization reflecting the pharmaceutical industry's high level of confidence in the accuracy of its clinical data. The stability of this indicator guarantees the reliability of investments in a proven industry partner.